NO317731B1 - Ikke selvinaktiverende, malrettet retroviral ekspresjonsvektorer - Google Patents

Ikke selvinaktiverende, malrettet retroviral ekspresjonsvektorer Download PDF

Info

Publication number
NO317731B1
NO317731B1 NO19970902A NO970902A NO317731B1 NO 317731 B1 NO317731 B1 NO 317731B1 NO 19970902 A NO19970902 A NO 19970902A NO 970902 A NO970902 A NO 970902A NO 317731 B1 NO317731 B1 NO 317731B1
Authority
NO
Norway
Prior art keywords
retroviral vector
retroviral
stated
gene
vector
Prior art date
Application number
NO19970902A
Other languages
English (en)
Norwegian (no)
Other versions
NO970902D0 (no
NO970902L (no
Inventor
Michael Robert Saller
Henry Walter Guenzburg
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Publication of NO970902D0 publication Critical patent/NO970902D0/no
Publication of NO970902L publication Critical patent/NO970902L/no
Publication of NO317731B1 publication Critical patent/NO317731B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Road Signs Or Road Markings (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
NO19970902A 1994-09-02 1997-02-27 Ikke selvinaktiverende, malrettet retroviral ekspresjonsvektorer NO317731B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (en) 1994-09-02 1995-09-01 Non self-inactivating, expression targeted retroviral vectors

Publications (3)

Publication Number Publication Date
NO970902D0 NO970902D0 (no) 1997-02-27
NO970902L NO970902L (no) 1997-04-24
NO317731B1 true NO317731B1 (no) 2004-12-13

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970902A NO317731B1 (no) 1994-09-02 1997-02-27 Ikke selvinaktiverende, malrettet retroviral ekspresjonsvektorer

Country Status (20)

Country Link
US (1) US7531353B1 (de)
EP (1) EP0779929B1 (de)
JP (1) JP4037446B2 (de)
CN (1) CN1117156C (de)
AT (1) ATE200517T1 (de)
AU (1) AU688590B2 (de)
BR (1) BR9508664A (de)
CA (1) CA2198210C (de)
DE (1) DE69520681T2 (de)
DK (1) DK0779929T5 (de)
EE (1) EE03492B1 (de)
ES (1) ES2156945T3 (de)
FI (1) FI970892A0 (de)
HU (1) HU221607B (de)
MX (1) MX9701544A (de)
NO (1) NO317731B1 (de)
NZ (1) NZ292897A (de)
PL (1) PL184375B1 (de)
RU (1) RU2199585C2 (de)
WO (1) WO1996007748A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9701544A (es) 1994-09-02 1998-03-31 Gsf Forschungszentrum Umwelt Vectores de expresion retrovirales dirigidos, no autoinactivantes.
ATE238427T1 (de) * 1995-03-09 2003-05-15 Austrian Nordic Biotherapeutic Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
WO1997001357A1 (en) 1995-06-27 1997-01-16 Bavarian Nordic Research Institute A/S Encapsulated cells producing viral particles
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
AU7291696A (en) * 1995-10-13 1997-04-30 Bavarian Nordic Research Institute A/S Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
IL125795A0 (en) 1996-03-27 1999-04-11 Bavarian Nordic Res Inst As Retroviral vectors encoding a cytochrome p450 gene
EP0961830A1 (de) * 1997-01-29 1999-12-08 Neurosearch A/S Expressionvektoren und methoden zur in vivo expression von therapeutischen polypeptiden
ES2373406T3 (es) * 1997-12-22 2012-02-03 Oxford Biomedica (Uk) Limited Vectores basados en el virus de la anemia infecciosa equina (vaie).
ATE278029T1 (de) 1998-01-06 2004-10-15 Inst Virologie Teilrechtsfaehi Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
WO2000066758A1 (en) * 1999-04-29 2000-11-09 Aarhus University Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2002064805A2 (en) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Replication competent non-mammalian retroviral vectors
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem
CN120866241B (zh) * 2025-09-28 2026-01-30 深圳细胞谷生物医药有限公司 通过稳定细胞系生产工程化类病毒颗粒的方法及其工程化类病毒颗粒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504344A (ja) 1988-05-17 1990-12-13 スローン‐ケツテリング・インステイテユート・フオー・キヤンサー・リサーチ レトロウイルスベクター
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
MX9701544A (es) 1994-09-02 1998-03-31 Gsf Forschungszentrum Umwelt Vectores de expresion retrovirales dirigidos, no autoinactivantes.
ATE238427T1 (de) * 1995-03-09 2003-05-15 Austrian Nordic Biotherapeutic Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
JPH11508441A (ja) * 1995-03-09 1999-07-27 ババリアン・ノルディック・リサーチ・インスティテュート・アクティーゼルスカブ 遺伝子治療用の新規組換えｄｎａベクター
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
EE9700040A (et) 1997-08-15
FI970892L (fi) 1997-02-28
NO970902D0 (no) 1997-02-27
CN1117156C (zh) 2003-08-06
PL184375B1 (pl) 2002-10-31
RU2199585C2 (ru) 2003-02-27
HK1001527A1 (en) 1998-06-26
DE69520681T2 (de) 2001-11-29
DK0779929T5 (da) 2001-08-13
JP4037446B2 (ja) 2008-01-23
JPH10507628A (ja) 1998-07-28
CA2198210A1 (en) 1996-03-14
HU221607B (hu) 2002-11-28
US7531353B1 (en) 2009-05-12
EE03492B1 (et) 2001-08-15
CN1159210A (zh) 1997-09-10
ATE200517T1 (de) 2001-04-15
AU688590B2 (en) 1998-03-12
DE69520681D1 (de) 2001-05-17
EP0779929B1 (de) 2001-04-11
NZ292897A (en) 1998-08-26
BR9508664A (pt) 1998-01-06
NO970902L (no) 1997-04-24
EP0779929A1 (de) 1997-06-25
DK0779929T3 (da) 2001-05-07
AU3520195A (en) 1996-03-27
FI970892A7 (fi) 1997-02-28
CA2198210C (en) 2006-07-11
PL319033A1 (en) 1997-07-21
WO1996007748A1 (en) 1996-03-14
MX9701544A (es) 1998-03-31
ES2156945T3 (es) 2001-08-01
HUT76974A (hu) 1998-01-28
FI970892A0 (fi) 1997-02-28

Similar Documents

Publication Publication Date Title
US6117681A (en) Pseudotyped retroviral particles
US6333195B1 (en) Crossless retroviral vectors
US6485965B1 (en) Replicating or semi-replicating viral constructs, preparation and uses for gene delivery
NO317731B1 (no) Ikke selvinaktiverende, malrettet retroviral ekspresjonsvektorer
US7022319B1 (en) Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
EP1115879B1 (de) Retrovirale partikel, geschützt gegen komplementvermittelte lyse
EP0892852A2 (de) Cytochrom p450 transduzierende retrovirale vektoren
EP0817860B1 (de) Pseudotypisierte retrovirale vektoren
US6821776B1 (en) Reconstituting retroviral vector (recon vector) for targeted gene expression
JPH11507244A (ja) Ｓｒｖ−３エンベロープ糖タンパク質配列で偽型化したレトロウイルスベクター
EP1059356B1 (de) Replizierende retrovirale Konstrukte, ihre Herstellung und Verwendungen für den Gentransfer
Maurya et al. Retroviral vectors and gene therapy: an update
KR100527096B1 (ko) 비자가-비활성화표적화된발현레트로바이러스벡터들
Hodgson et al. Overview: Retroviral Vectors for Gene Therapy and Transgenics
Fassati et al. Retroviral vectors
Robbins Retroviral vectors
AU2004202502B2 (en) Retroviral particles protected against complement mediated destruction

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees